18F-FDG PET/CT Positive and 68Ga-DOTA-Bombesin PET/CT Negative Focus of Benign Apocrine Metaplasia Mimicking Malignancy
Clinical Nuclear Medicine, cilt.50, sa.5, 2025 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 50 Sayı: 5
- Basım Tarihi: 2025
- Doi Numarası: 10.1097/rlu.0000000000005709
- Dergi Adı: Clinical Nuclear Medicine
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Anahtar Kelimeler: gastrin-releasing peptide receptor, Ga-68-DOTA-Bombesin PET-CT, F-18-FDG PET-CT, breast cancer
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Gastrin-releasing peptide receptor (GRPR) is a promising agent for imaging and development of theranostic radioligands in estrogen receptor (ER)-positive luminal type breast cancer (BC) and may show expression not only in primary malignant lesions but also in lymph node metastases and distant organ metastases. We would like to present a lesion diagnosed as benign apocrine metaplasia in a 45-year-old woman diagnosed with BC, which was negative in 68Ga-DOTA-Bombesin PET-CT and false positive in 18F-FDG PET-CT imaging, within the scope of the ongoing study.